BridgeBio Oncology Therapeutics, Inc. (BBOT) stock
BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.94−0.04 (-2.02%)
Close on Nov 17, 2026Market cap $155.54MP/E –Yield –
BridgeBio Oncology Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
BridgeBio Oncology Therapeutics's market cap was $205.09M on Nov 11, 2026, against $974.91M a year earlier.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $205.09M | -79.3% |
| 2025 | Dec 31, 2025 | $991.54M | – |
See a number that looks wrong?